Co-Authors
This is a "connection" page, showing publications co-authored by Ewen Harrison and Cameron Fairfield.
Connection Strength
0.407
-
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021 07 17; 398(10296):223-237.
Score: 0.060
-
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021 Aug; 2(8):e354-e365.
Score: 0.059
-
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021 Jul; 3(7):e498-e506.
Score: 0.059
-
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol. 2021 03 10; 6(57).
Score: 0.058
-
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
Score: 0.058
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 09 09; 370:m3339.
Score: 0.056
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.056